Cargando…
Potential recombinant vaccine against influenza A virus based on M2e displayed on nodaviral capsid nanoparticles
Influenza A virus poses a major threat to human health, causing outbreaks from time to time. Currently available vaccines employ inactivated viruses of different strains to provide protection against influenza virus infection. However, high mutation rates of influenza virus hemagglutinin (H) and neu...
Autores principales: | Yong, Chean Yeah, Yeap, Swee Keong, Ho, Kok Lian, Omar, Abdul Rahman, Tan, Wen Siang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396508/ https://www.ncbi.nlm.nih.gov/pubmed/25897220 http://dx.doi.org/10.2147/IJN.S77405 |
Ejemplares similares
-
An Influenza A Vaccine Based on the Extracellular Domain of Matrix 2 Protein Protects BALB/C Mice Against H1N1 and H3N2
por: Ong, Hui Kian, et al.
Publicado: (2019) -
Advances in the study of nodavirus
por: Yong, Chean Yeah, et al.
Publicado: (2017) -
Infectious hematopoietic necrosis virus: advances in diagnosis and vaccine development
por: Yong, Chean Yeah, et al.
Publicado: (2019) -
Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus
por: Yong, Chean Yeah, et al.
Publicado: (2019) -
Regulation of Proteolytic Activity to Improve the Recovery of Macrobrachium rosenbergii Nodavirus Capsid Protein
por: Selvaraj, Bethilda Anne, et al.
Publicado: (2021)